Catalyst Pharmaceuticals Inc (CPRX) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $24.88
• Market Cap: $3.06B
• P/E Ratio: 14.12
• EPS: $1.76
• 52-Week High: $26.58
• 52-Week Low: $19.05

Market Sentiment

Catalyst Pharmaceuticals Inc currently has a Bullish sentiment score of 0.38.

About Catalyst Pharmaceuticals Inc

Catalyst Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company headquartered in Coral Gables, Florida, specializing in the development and commercialization of innovative therapies for rare neuromuscular and chronic neurological diseases. The company is dedicated to addressing significant unmet medical needs in the United States through a targeted treatment portfolio that aims to improve the quality of life for patients with debilitating conditions often neglected by conventio...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Catalyst Pharmaceuticals Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does CPRX pay dividends?

Catalyst Pharmaceuticals Inc (CPRX) does not currently pay a regular dividend.

What is CPRX's P/E ratio?

Catalyst Pharmaceuticals Inc has a price-to-earnings (P/E) ratio of 14.12.

What is CPRX's market cap?

Catalyst Pharmaceuticals Inc (CPRX) has a market capitalization of $3.06B with a current stock price of $24.88.